Racial Disparities in Diagnosis and Treatment of Major Depression

People worldwide are suffering with mental health challenges now more than ever. Social distancing and remote work and school have translated into emotional distancing for many. The pandemic has magnified the challenges at home and abroad, and some racial and ethnic groups suffer disproportionately.1,2 Quantifying the extent of racial and ethnic inequities in mental health can help us better understand how to address them.

This study investigates disparities in the prevalence of diagnosis and treatment of major depressive disorder, or major depression3, between majority white, Black and Hispanic communities. Our analysis spans 2016 to 2020 and is based on the medical claims of 3.1 million Blue Cross and Blue Shield (BCBS) commercially insured individuals with major depression between the ages of 12 and 64. For additional insights, we surveyed more than 2,700 adults, aged 18 to 75, about their attitudes and perspectives around mental health and how they access care.

This is the second in a series of reports supporting the Blue Cross and Blue Shield national strategy to address racial disparities in health. The first report in our series examined maternal health; future reports will explore disparities in diabetes and heart health.

Read Full Report

ENDNOTES

  1. World Health Organization (2022). Mental Health and COVID-19: Early evidence of the pandemic’s impact: Scientific brief, 02 March 2022.
  2. National Center for Health Statistics, U.S. Census Bureau (2022). Household Pulse Survey, Indicators of Anxiety or Depression based on Reported Frequency of Symptoms.
  3. ICD-10 codes in the F32 and F33 groupings.

The latest in health care, delivered.

Subscribe to stay in the know on health care industry news and insights.